
The agreement covers scheduled deliveries of the company’s MVA-BN vaccine, with optional flexibility provisions over the contract term.
Bavarian Nordic has been awarded a four-year contract by the UK government to supply its MVA-BN vaccine, the company said Monday.
The agreement was awarded through the UK Health Security Agency. Deliveries are scheduled across the contract term, which also includes optional flexibility provisions.
MVA-BN is a non-replicating vaccine indicated for the prevention of mpox and smallpox. Bavarian Nordic said the contract supports the UK’s long-term preparedness for infectious disease threats.
This article was produced with the help of AI technology. Based on reporting by the outlets listed above.